132 Annual Meeting Logo - Go to APHA Meeting Page  
APHA Logo - Go to APHA Home Page
Session: HPV: Clinician Practices and Women's Experiences
4327.0: Tuesday, November 9, 2004: 4:30 PM-6:00 PM
Oral
HPV: Clinician Practices and Women's Experiences
Human papillomavirus (HPV) is the most common sexually transmitted disease in the U.S. with about 5 million people acquiring genital HPV infection each year. A smaller number (about 12,000) of women who have HPV develop cervical cancer in the U.S. Although HPV is the main causative agent for cervical cancer, little is known about the impact of diagnosis and educational needs of women who test positive for high-risk HPV and their sex partners. Additionally, few studies on clinicians' knowledge and practices have been reported. The research findings presented in this session are from four of five sites (University of South Florida, Washington University, University of Oklahoma, and University of South Carolina) funded by the CDC to learn more about the effect of HPV on women's lives and their sex partners. One presentation focusing on health care providers is based on research being conducted by the CDC.
Learning Objectives: At the conclusion of the session, the participant will be able to: (1) Discuss the use of qualitative methods to conduct social and behavioral research on HPV; (2) Explain the effects and challenges of an HPV diagnosis on the lives of women and clinicians; and (3) Identify recommendations for future research on HPV.
Organizer(s):Heather M. Brandt, PhD, CHES
Moderator(s):Donna H. McCree, PhD, MPH, RPh
4:30 PMKnowledge, attitudes and practices about genital human papillomavirus (HPV) infection and HPV-related conditions among U.S. clinicians  [ Recorded presentation ]
Kathleen L. Irwin, MD, MPH, Hilda Shepeard, MBA, Rheta Barnes, MSN, MPH, Carol S. Freeman, BA, Crystal M. Freeman, PhD, MPH, Katherine Hsu, MD, Alison Friedman, MPH, Sureyya Hornston, PhD, Danuta Kasprzyk, PhD, Daniel E. Montaño, PhD
4:42 PMShould Clinicians Adhere to the KISS Principle?  [ Recorded presentation ]
Crystal M. Freeman, PhD, MPH, Danuta Kasprzyk, PhD, Daniel E. Montaño, PhD, Tara S. McPartland, MSW, MPH, Bethany A. Weaver, DO, MPH, Laura A. Koutsky, PhD, Rheta Barnes, MSN, MPH
4:54 PMReactions of focus group participants to health care professionals about a diagnosis of high-risk human papillomavirus (HR-HPV)  [ Recorded presentation ]
Vicki H. Wyatt, PhD, Robert M. Hamm, PhD, Kelly C. Juniper, MA, Katy D. Smith, MS, Donna H. McCree, PhD, MPH, RPh, Rilla Walker, BA, Allison O'Rourke, MPH, Scott W. Plunkett, PhD
5:06 PMUse of cognitive interviewing to develop a human papillomavirus (HPV) telephone questionnaire for women living in rural South Carolina (SC)  [ Recorded presentation ]
Heather M. Brandt, PhD, CHES, Patricia A. Sharpe, PhD, MPH, Donna H. McCree, PhD, MPH, RPh
5:18 PMWhy was disclosing an HPV diagnosis so easy? Reactions following women’s disclosure of HPV diagnosis to partners and significant others
Holly Rayko, MA, Jennifer Lee Packing-Ebuen, MA, Trisha E. Mueller, BS, Ellen M. Daley, PhD, MPH, Karen M. Perrin, PhD, MPH, RN, Mary McFarlane, PhD, Robert J. McDermott, PhD, Sandra F. Naoom, MSPH(c)
5:30 PMWhat it means to receive an HPV diagnosis: Do the new screening recommendations exacerbate misunderstanding?
Jennifer L. Packing-Ebuen, MA, Trisha E. Mueller, BS, Holly Rayko, MA, Ellen M. Daley, PhD, MPH, Karen M. Perrin, PhD, MPH, RN, Mary McFarlane, PhD, Robert J. McDermott, PhD, Sandra F. Naoom, MSPH(c), Jeffery E. Jensen, DO MS MPH MBA, Patricia Trow-Finney, PA
See individual abstracts for presenting author's disclosure statement and author's information.
Organized by:Women's Caucus
Endorsed by:APHA-Committee on Women's Rights; Alternative and Complementary Health Practices; Population, Family Planning, and Reproductive Health; Socialist Caucus
CE Credits:CME, Health Education (CHES), Nursing

The 132nd Annual Meeting (November 6-10, 2004) of APHA